Actavis

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Actavis sits in the top decile of US sponsors by registered trial count (#282 of 15,742 sponsors by registered trial count).

79 total trials none currently recruiting 79 completed early-phase tilt top decile by trial count

Actavis: 79 sponsored US clinical trials, none currently recruiting.

Actavis sponsors 79 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 79 completed. 27 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 13 trials.

Top-decile sponsor footprint

Actavis ranks in the top decile of sponsors by registered trial count (#282 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

79 of 79 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

79 total, page 2 of 2

COMPLETED Phase 1

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

NCT00864162
COMPLETED Phase 1

Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce

NCT00759954
COMPLETED Phase 1

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

NCT00865371
COMPLETED Phase 1

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

NCT00865410
COMPLETED Phase 1

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions

NCT00864019
COMPLETED Phase 1

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions

NCT00759356
COMPLETED Phase 1

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

NCT00864344
COMPLETED Phase 1

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

NCT00865462
COMPLETED Phase 1

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

NCT00863941
COMPLETED Phase 4

Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

NCT00782548
COMPLETED Phase 1

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

NCT00865436
COMPLETED Phase 1

A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions

NCT00865748
COMPLETED Phase 1

The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

NCT00865267
COMPLETED Phase 1

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

NCT00865605
COMPLETED Phase 1

A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions

NCT00865072
COMPLETED Phase 1

A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions

NCT00865852
COMPLETED Phase 1

A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions

NCT00865943
COMPLETED Phase 1

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

NCT00865241
COMPLETED Phase 1

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions

NCT00864734
COMPLETED Phase 1

A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions

NCT00865839
COMPLETED Phase 1

A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions

NCT00864669
COMPLETED Phase 1

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions

NCT00865696
COMPLETED Phase 1

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions

NCT00865384
COMPLETED Phase 1

A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions

NCT00865059
COMPLETED Phase 1

A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting Conditions

NCT00865423
COMPLETED Phase 1

A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions

NCT00864760
COMPLETED Phase 1

A Limited Food Effect Study of Gabapentin 800 mg Tablets

NCT00865631
COMPLETED Phase 1

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions

NCT00864058
COMPLETED Phase 1

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions

NCT00864305
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 51
Phase 3 26
Phase 4 1

Therapeutic Areas

Healthy 13
Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe 1
Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe 1
Vaginal Discharge Color, Odor, and Consistency 1
Signs and Symptoms to be Evaluated and Recorded Include 1
Bacterial Vaginosis 1
Actinic Keratosis 1
Acne 1

How the Actavis early-phase archive is shaped

79 indexed studies, none listed as recruiting (0% open); 79 completed (100%).

Phase mix: 27 late (III/IV) vs 51 early (I/II) (early-phase heavy).

Top condition: Healthy (13 trials), 7 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Actavis: archived-pipeline peers nationwide

Peers matched on 79 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Actavis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080100 0%5%10%15%20% Total trials Recruiting share ActavisBioMarin PharmaceuticalChildren's Healthcare of AtlantaRANDEMD Serono Research & Development Institute10xBio22nd Century Group23andMe3-C Institute for Social Development
Actavis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Actavis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 79 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Actavis page

79 registered trials is a research-attention snapshot, not an endorsement of Actavis or any single study.

  • None of Actavis's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Healthy is the condition Actavis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Actavis pipeline card: 79 registered trials from official public datasets.Report a data error.